Literature DB >> 23018162

Prostate cancer antigen 3 to select men for prostate biopsy: stop, go, or proceed with caution?

Michael R Abern, Stephen J Freedland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23018162     DOI： 10.1016/j.eururo.2012.09.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy.

Authors:  Alain Ruffion; Marian Devonec; Denis Champetier; Myriam Decaussin-Petrucci; Claire Rodriguez-Lafrasse; Philippe Paparel; Paul Perrin; Virginie Vlaeminck-Guillem
Journal:  Int J Mol Sci       Date:  2013-08-29       Impact factor: 5.923

2.  Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.

Authors:  Jose Rubio-Briones; Angel Borque; Luis M Esteban; Juan Casanova; Antonio Fernandez-Serra; Luis Rubio; Irene Casanova-Salas; Gerardo Sanz; Jose Domínguez-Escrig; Argimiro Collado; Alvaro Gómez-Ferrer; Inmaculada Iborra; Miguel Ramírez-Backhaus; Francisco Martínez; Ana Calatrava; Jose A Lopez-Guerrero
Journal:  BMC Cancer       Date:  2015-09-11       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.